05.07.24 -- Looking For Help With Your Biologic API Or Drug Product?

Reaching clinical trials with your innovative biologic is paramount, but cell line development bottlenecks can stall progress. Abzena's platforms cut through these delays, reducing timelines to just 15 weeks from sequence to research cell bank.

Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.

Early manufacturability assessments, complete cGMP solutions, and everything in between. FUJIFILM Diosynth Biotechnologies is a leading provider of cell culture services for biologics, advancing and delivering life-changing therapies.

IDT Biologika is a globally operating CDMO that specializes in vaccines, advanced therapies, and the commercial fill/finish of biologics and sterile injectables. We provide fully integrated services for clinical and commercial GMP manufacturing.

Catalent has the passion to accelerate, simplify, and de-risk your next biologic from development through clinical and commercial supply. Leverage our deep expertise and collaborative approach to bring your biologic successfully to clinic and market.

A new program designed to deliver effective IND-ready GMP material for biopharmaceutical developers, AGCellerate offers guaranteed amounts at fixed timelines and costs – accelerating projects through development and into clinical phases.

Much more than a CMO, AbbVie is an established biopharmaceutical partner providing comprehensive support at every phase of your mAb’s development to commercial life cycle. Explore exceptional end-to-end Biologics capabilities.

CEO and Founder of INCOG BioPharma Services, Cory Lewis, explains how the company is proud to be able to manufacture for the future of medicine. Your drug product is in safe hands. Honesty, integrity, transparency, and support every step of the way.

Your biotherapeutic deserves the reliability and peace of mind that only an experienced microbial fermentation partner can provide. Ajinomoto Bio-Pharma Services is a leader in recombinant protein, plasmid DNA, and critical raw material manufacturing.

Vitaldose EVA is an enabling technology that formulators can leverage to create effective implants for long-acting controlled release therapeutics. Many implant designs are possible ranging from single phase to co-continuous structures.

We are your life science solutions partner who ensures you have the right end-to-end solutions to address challenges in early development, commercialization, and post-market for your combination products, biologics, and medical devices.